References analysis of the Wikipedia article "FANCF" in the Galician version

archive.org (Global: 6^th place; Galician: 8^th place)

Léveillé F, Blom E, Medhurst AL, Bier P, Laghmani el H, Johnson M, Rooimans MA, Sobeck A, Waisfisz Q, Arwert F, Patel KJ, Hoatlin ME, Joenje H, de Winter JP (September 2004). "The Fanconi anemia gene product FANCF is a flexible adaptor protein". The Journal of Biological Chemistry 279 (38): 39421–30. PMID 15262960. doi:10.1074/jbc.M407034200.

Gordon SM, Buchwald M (July 2003). "Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems". Blood 102 (1): 136–41. PMID 12649160. doi:10.1182/blood-2002-11-3517.

Pace P, Johnson M, Tan WM, Mosedale G, Sng C, Hoatlin M, de Winter J, Joenje H, Gergely F, Patel KJ (July 2002). "FANCE: the link between Fanconi anaemia complex assembly and activity". The EMBO Journal 21 (13): 3414–23. PMC 125396. PMID 12093742. doi:10.1093/emboj/cdf355.

Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, Gissmann L, Dürst M, Pothuri B, Murty VV (May 2004). "Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer". Cancer Research 64 (9): 2994–7. PMID 15126331. doi:10.1158/0008-5472.can-04-0245.

Bakker ST, van de Vrugt HJ, Visser JA, Delzenne-Goette E, van der Wal A, Berns MA, van de Ven M, Oostra AB, de Vries S, Kramer P, Arwert F, van der Valk M, de Winter JP, te Riele H (January 2012). "Fancf-deficient mice are prone to develop ovarian tumours". The Journal of Pathology 226 (1): 28–39. PMID 21915857. doi:10.1002/path.2992.

doi.org (Global: 2^nd place; Galician: 7^th place)

dx.doi.org

Joenje H, Oostra AB, Wijker M, di Summa FM, van Berkel CG, Rooimans MA, Ebell W, van Weel M, Pronk JC, Buchwald M, Arwert F (October 1997). "Evidence for at least eight Fanconi anemia genes". American Journal of Human Genetics 61 (4): 940–4. PMC 1715980. PMID 9382107. doi:10.1086/514881.

de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, Scheper RJ, Kruyt FA, Hoatlin ME, Joenje H (November 2000). "The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG". Human Molecular Genetics 9 (18): 2665–74. PMID 11063725. doi:10.1093/hmg/9.18.2665.

Medhurst AL, Huber PA, Waisfisz Q, de Winter JP, Mathew CG (February 2001). "Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway". Human Molecular Genetics 10 (4): 423–9. PMID 11157805. doi:10.1093/hmg/10.4.423.

Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, Wang W (October 2003). "A novel ubiquitin ligase is deficient in Fanconi anemia". Nature Genetics 35 (2): 165–70. PMID 12973351. doi:10.1038/ng1241.

Kottemann MC, Smogorzewska A (January 2013). "Fanconi anaemia and the repair of Watson and Crick DNA crosslinks". Nature 493 (7432): 356–63. PMC 3700363. PMID 23325218. doi:10.1038/nature11863.

Pradhan A, Ustiyan V, Zhang Y, Kalin TV, Kalinichenko VV (January 2016). "Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response". Oncotarget 7 (2): 1912–26. PMC 4811506. PMID 26625197. doi:10.18632/oncotarget.6422.

Kastan MB (April 2008). "DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture". Molecular Cancer Research 6 (4): 517–24. PMID 18403632. doi:10.1158/1541-7786.MCR-08-0020.

Harper JW, Elledge SJ (December 2007). "The DNA damage response: ten years after". Molecular Cell 28 (5): 739–45. PMID 18082599. doi:10.1016/j.molcel.2007.11.015.

Dietlein F, Reinhardt HC (December 2014). "Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy". Clinical Cancer Research 20 (23): 5882–7. PMID 25451105. doi:10.1158/1078-0432.CCR-14-1165.

O'Hagan HM, Mohammad HP, Baylin SB (2008). "Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island". PLoS Genetics 4 (8): e1000155. PMC 2491723. PMID 18704159. doi:10.1371/journal.pgen.1000155.

Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (July 2007). "DNA damage, homology-directed repair, and DNA methylation". PLoS Genetics 3 (7): e110. PMC 1913100. PMID 17616978. doi:10.1371/journal.pgen.0030110.

Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD (May 2003). "Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors". Nature Medicine 9 (5): 568–74. PMID 12692539. doi:10.1038/nm852.

Ding JJ, Wang G, Shi WX, Zhou HH, Zhao EF (January 2016). "Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer". Reproductive Sciences 23 (1): 24–30. PMID 26507869. doi:10.1177/1933719115612136.

Wang Z, Li M, Lu S, Zhang Y, Wang H (March 2006). "Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway". Cancer Biology & Therapy 5 (3): 256–60. PMID 16418574. doi:10.4161/cbt.5.3.2380.

Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT (January 2004). "Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival". Oncogene 23 (4): 1000–4. PMID 14647419. doi:10.1038/sj.onc.1207256.

Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV (May 2004). "Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors". Molecular Cancer 3: 16. PMC 420487. PMID 15149548. doi:10.1186/1476-4598-3-16.

Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM (February 2012). "Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA". Proceedings of the National Academy of Sciences of the United States of America 109 (8): 3024–9. PMC 3286983. PMID 22315424. doi:10.1073/pnas.1200010109.

nih.gov (Global: 4^th place; Galician: 6^th place)

ncbi.nlm.nih.gov

"Entrez Gene: FANCF Fanconi anemia, complementation group F".

Harper JW, Elledge SJ (December 2007). "The DNA damage response: ten years after". Molecular Cell 28 (5): 739–45. PMID 18082599. doi:10.1016/j.molcel.2007.11.015.

Guo M, Alumkal J, Drachova T, Gao D, Marina SS, Jen J, Herman JG (March 2015). "CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer". Discovery Medicine 19 (104): 151–8. PMID 25828518.

FANCF (Galician Wikipedia)

archive.org (Global: 6^th place; Galician: 8^th place)

doi.org (Global: 2^nd place; Galician: 7^th place)

dx.doi.org

intechopen.com (Global: low place; Galician: 3,386^th place)

nih.gov (Global: 4^th place; Galician: 6^th place)

ncbi.nlm.nih.gov

FANCF (Galician Wikipedia)

archive.org (Global: 6th place; Galician: 8th place)

doi.org (Global: 2nd place; Galician: 7th place)

dx.doi.org

intechopen.com (Global: low place; Galician: 3,386th place)

nih.gov (Global: 4th place; Galician: 6th place)

ncbi.nlm.nih.gov

archive.org (Global: 6^th place; Galician: 8^th place)

doi.org (Global: 2^nd place; Galician: 7^th place)

intechopen.com (Global: low place; Galician: 3,386^th place)

nih.gov (Global: 4^th place; Galician: 6^th place)